NASDAQMaterialsConstruction MaterialsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for SMID yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Resolve Nasdaq Listing Rule 5250(c)(1) compliance issues | If it resolves Nasdaq compliance issues, it can stabilize and improve. | Under Pressure | Failure to resolve Nasdaq compliance leading to delisting notice | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in a supplied disclosure. Management reported: “smid_ex991.htm EXHIBIT 99.1 Smith-Midland Announces Receipt of Nasdaq Letter MIDLAND, VA – June 3, 2026 – Smith-Midland Corporation (NASDAQ: SMID) (the “Company”), a provider of innovative, high-quality proprietary and patented precast concrete products and systems, today announced it received a letter from Nasdaq, dated May 29, 2026, indicating it was not in compliance with Nasdaq listing rule 5250(c)(1), which requires the timely filing of all required periodic financial reports with the Securities and Exchange Commission.” “The Company has replaced the staff member and is working diligently to complete and file the Quarterly Report as soon as practicable.” |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
SMID is a small company with a growth thesis tied to product sales, rental fleet expansion, and production capacity. Its long-term thesis is marked intact, but confidence has fallen to low and the risk level is elevated.
The evidence describes SMID as cheap versus peers, with a small expectations gap and a justified priced-in assessment. The valuation model has high confidence, but overall confidence in the thesis is low, so the cheap comparison alone does not resolve the business risks.
Near term, sales delivery is mixed: second-quarter 2026 revenue was below the prior-year quarter, while management still expects full-year 2026 product sales to exceed 2025. Management has begun spending on rental fleet and production expansion, but the initiative is early, and delayed filing led to a Nasdaq compliance notice.
The next call is a key near-term test because a guidance cut is identified as a meaningful negative. Over the multi-year view, the thesis also depends on stronger product sales and execution of expansion plans; continued strength from sector peers could support the Materials backdrop, while weaker results could remove that tailwind.
The 1-to-3-year view remains intact, but confidence is low and execution, filing compliance, and sector conditions are important swing factors. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Increase product sales in 2026 versus 2025 | Smith-Midland aims to grow product sales in 2026 compared to 2025. | Broken | YoY revenue growth falls below 0% in FY26 | Revenue growth: -10.78% FY2026-Q2; GAAP. Published target: >0% YoY revenue growth. Annual target cannot be compared with a quarterly or TTM observation. Aug 14, 2026-10.78057 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: ““Our backlog as of August 1, 2026 increased by 19% over the backlog in the prior quarter and 6% on a year-over-year basis thanks to several recent project awards, including the third largest contract in the history of the company.” “Backlog was approximately $57.4 million recorded as of August 1, 2026 compared to $54 million in backlog one year prior.” Revenue was $23.363 million in 2026-Q2. Delivery assessment Nov 4, 2026 |
Maintain valuation support with PE below peer median | A supporting condition in Smith-Midland Corp.'s published investment case. The stated target is PE <= 18. | Intact | PE rises above 18 without fundamental improvement | P/E (TTM): 12.42x As of 2026-11-04; trailing twelve months. The target timing and basis require a separate assessment. Nov 4, 202612.4226 ratio · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.